SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23)

Oncogene

Volumn 25, Issue 45, 2006, Pages 6147-6152

  Cerveira, N ^a   Correia, C ^a   Bizarro, S ^a   Pinto, C ^a   Lisboa, S ^a   Mariz, J M ^a   Marques, M ^a   Teixeira, M R ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Fusion oncogenes; MLL SEPT2; t(2; 11)(q37; q23); Therapy related AML

Indexed keywords

DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); RNA; SEPTIN; SEPTIN 1; SEPTIN 4; SEPTIN 5; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 2Q; CHROMOSOME TRANSLOCATION; CONSENSUS SEQUENCE; CYTOGENETICS; DNA DETERMINATION; DNA SEQUENCE; DNA STRAND BREAKAGE; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE FUSION; GENE LOCATION; GENE REARRANGEMENT; HUMAN; INTRON; MITOSIS; MLL GENE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; RNA ANALYSIS; SEPT2 GENE; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 2; DNA, NEOPLASM; EXONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PHOSPHORIC MONOESTER HYDROLASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSLOCATION, GENETIC;

EID: 33749836689     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209626     Document Type: Article

References (51)

1. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. (2003). Hum Mutat 22: 229-244.
2. Berger R, Flandrin G, Bernheim A, Le Coniat M, Vecchione D, Pacot A et al. (1987). Cancer Genet Cytogenet 29: 9-21.
3. Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF et al. (2000). Proc Natl Acad Sci USA 97: 9168-9173.
4. Chinwalla V, Chien A, Odero M, Neilly MB, Zeleznik-Le NJ, Rowley JD. (2003). Oncogene 22: 1400-1410.
5. Chuzhanova N, Abeysinghe SS, Krawczak M, Cooper DN. (2003). Hum Mutat 22: 245-251.
6. Daser A, Rabbitts TH. (2005). Semin Cancer Biol 15: 175-188.
7. DeLozier-Blanchet CD, Cabrol C, Werner-Favre C, Beris P, Engel E. (1985). Cancer Genet Cytogenet 16: 95-102.
8. Fischer K, Frohling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S et al. (1997). Blood 89: 2036-2041.
9. Fuchs U, Rehkamp G, Haas OA, Slany R, Konig M, Bojesen S et al. (2001). Proc Natl Acad Sci USA 98: 8756-8761.
10. Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR. (2005). J Pathol 205: 154-171.
11. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G et al. (1992). Cell 71: 701-708.
12. Hall PA, Russell SE. (2004). J Pathol 204: 489-505.
13. Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F et al. (1998). Leukemia 12: 811-822.
14. Hayette S, Tigaud I, Vanier A, Martel S, Corbo L, Charrin C et al. (2000). Oncogene 19: 4446-4450.
15. Huret JL. (2005). Atlas of Genetics and Cytogenetics in Oncology and Haematology http://www.infobiogen.fr/ services/chromcancer/Genes/MLL.html.
16. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M et al. (1997). Blood 90: 4699-4704.
17. ISCN (1995). An International System for Human Cytogenetic Nomenclature. Karger: Basel.
18. Kinoshita M, Kumar S, Mizoguchi A, Ide C, Kinoshita A, Haraguchi T et al. (1997). Genes Dev 11: 1535-1547.
19. Kojima K, Sakai I, Hasegawa A, Niiya H, Azuma T, Matsuo Y et al. (2004). Leukemia 18: 998-1005.
20. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. (2000). Proc Natl Acad Sci USA 97: 2145-2150.
21. Li ZY, Liu DP, Liang CC. (2005). Leukemia 19: 183-190.
22. Marosi C, Koller U, Koller-Weber E, Schwarzinger I, Schneider B, Jager U et al. (1992). Cancer Genet Cytogenet 61: 14-25.
23. Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM et al. (1998). Proc Natl Acad Sci USA 95: 6413-6418.
24. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD et al. (2002). Mol Cell 10: 1107-1117.
25. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R et al. (2002). Mol Cell 10: 1119-1128.
26. Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T et al. (2005). J Clin Invest 115: 919-929.
27. Ono R, Taki T, Taketani T, Kawaguchi H, Taniwaki M, Okamura T et al. (2002). Cancer Res 62: 333-337.
28. Osaka M, Rowley JD, Zeleznik-Le NJ. (1999). Proc Natl Acad Sci USA 96: 6428-6433.
29. Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C et al. (1996). Blood 87: 2496-2505.
30. Popovic R, Zeleznik-Le NJ. (2005). J Cell Biochem 95: 234-242.
31. Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H et al. (1994). Proc Natl Acad Sci USA 91: 8107-8111.
32. Pui CH, Relling MV. (2000). Br J Haematol 109: 13-23.
33. Rasmussen SW. (2004). SEQ Tools Version 8.2 - Build 101 http://www.seqtools.dk.
34. Rudiger NS, Gregersen N, Kielland-Brandt MC. (1995). Nucleic Acids Res 23: 256-260.
35. Russell SE, Hall PA. (2005). Br J Cancer 93: 499-503.
36. Satake N, Maseki N, Nishiyama M, Kobayashi H, Sakurai M, Inaba H et al. (1999). Leukemia 13: 1013-1017.
37. Savage PD, Shapiro M, Langdon WY, Geurts van Kessel AD, Seuanez HN, Akao Y et al. (1991). Cytogenet Cell Genet 56: 112-115.
38. Slany RK. (2005). Hematol Oncol 23: 1-9.
39. Smit AFA, Hubley R, Green P. (2004). RepeatMasker Open-3.0 http://www.repeatmasker.org.
40. So CW, Caldas C, Liu MM, Chen SJ, Huang QH, Gu LJ et al. (1997). Proc Natl Acad Sci USA 94: 2563-2568.
41. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B et al. (1997). Proc Natl Acad Sci USA 94: 8732-8737.
42. Spiliotis ET, Kinoshita M, Nelson WJ. (2005). Science 307: 1781-1785.
43. Strehl S, Borkhardt A, Slany R, Fuchs UE, Konig M, Haas OA. (2003). Oncogene 22: 157-160.
44. Surka MC, Tsang CW, Trimble WS. (2002). Mol Biol Cell 13: 353235-353245.
45. Taki T, Kano H, Taniwaki M, Sako M, Yanagisawa M, Hayashi Y. (1999b). Proc Natl Acad Sci USA 96: 14535-14540.
46. Taki T, Ohnishi H, Shinohara K, Sako M, Bessho F, Yanagisawa M et al. (1999a). Cancer Res 59: 4261-4265.
47. Taki T, Sako M, Tsuchida M, Hayashi Y. (1997). Blood 89: 3945-3950.
48. Tkachuk DC, Kohler S, Cleary ML. (1992). Cell 71: 691-700.
49. von Bergh AR, Wijers PM, Groot AJ, van Zelderen-Bhola S, Falkenburg JH, Kluin PM et al. (2004). Genes Chromosomes Cancer 39: 324-334.
50. Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP et al. (1993). J Clin Oncol 11: 209-217.
51. Yamamoto K, Seto M, Iida S, Komatsu H, Kamada N, Kojima S et al. (1994). Blood 83: 2912-2921.